You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Lacosamide Sandoz (lacosamide) tablets are indicated as:
monotherapy in the treatment of partial onset seizures with or without secondary generalisation
in patients with epilepsy aged 16 years and older.
add-on therapy in the treatment of partial onset seizures with or without secondary generalisation
in patients with epilepsy aged 4 years and older.
add-on therapy in the treatment of primary generalised tonic-clonic seizures in patients with
idiopathic generalised epilepsy aged 4 years and older.,Paediatric patents weighing less than 50 kg should not receive Lacosamide Sandoz film-coated
tablets. Paediatric patients weighing less than 50 kg should be accurately dosed on a mg/kg basis
with other lacosamide products.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on September, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Lacosamide Sandoz (lacosamide) tablets are indicated as:
monotherapy in the treatment of partial onset seizures with or without secondary generalisation
in patients with epilepsy aged 16 years and older.
add-on therapy in the treatment of partial onset seizures with or without secondary generalisation
in patients with epilepsy aged 4 years and older.
add-on therapy in the treatment of primary generalised tonic-clonic seizures in patients with
idiopathic generalised epilepsy aged 4 years and older.,Paediatric patents weighing less than 50 kg should not receive Lacosamide Sandoz film-coated
tablets. Paediatric patients weighing less than 50 kg should be accurately dosed on a mg/kg basis
with other lacosamide products.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Lacosamide Sandoz (lacosamide) tablets are indicated as:
monotherapy in the treatment of partial onset seizures with or without secondary generalisation
in patients with epilepsy aged 16 years and older.
add-on therapy in the treatment of partial onset seizures with or without secondary generalisation
in patients with epilepsy aged 4 years and older.
add-on therapy in the treatment of primary generalised tonic-clonic seizures in patients with
idiopathic generalised epilepsy aged 4 years and older.,Paediatric patents weighing less than 50 kg should not receive Lacosamide Sandoz film-coated
tablets. Paediatric patients weighing less than 50 kg should be accurately dosed on a mg/kg basis
with other lacosamide products.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Lacosamide Sandoz (lacosamide) tablets are indicated as:
monotherapy in the treatment of partial onset seizures with or without secondary generalisation
in patients with epilepsy aged 16 years and older.
add-on therapy in the treatment of partial onset seizures with or without secondary generalisation
in patients with epilepsy aged 4 years and older.
add-on therapy in the treatment of primary generalised tonic-clonic seizures in patients with
idiopathic generalised epilepsy aged 4 years and older.,Paediatric patents weighing less than 50 kg should not receive Lacosamide Sandoz film-coated
tablets. Paediatric patients weighing less than 50 kg should be accurately dosed on a mg/kg basis
with other lacosamide products.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on September, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Lacosamide Sandoz (lacosamide) tablets are indicated as:
monotherapy in the treatment of partial onset seizures with or without secondary generalisation
in patients with epilepsy aged 16 years and older.
add-on therapy in the treatment of partial onset seizures with or without secondary generalisation
in patients with epilepsy aged 4 years and older.
add-on therapy in the treatment of primary generalised tonic-clonic seizures in patients with
idiopathic generalised epilepsy aged 4 years and older.,Paediatric patents weighing less than 50 kg should not receive Lacosamide Sandoz film-coated
tablets. Paediatric patients weighing less than 50 kg should be accurately dosed on a mg/kg basis
with other lacosamide products.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on September, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Lacosamide Sandoz (lacosamide) tablets are indicated as:
monotherapy in the treatment of partial onset seizures with or without secondary generalisation
in patients with epilepsy aged 16 years and older.
add-on therapy in the treatment of partial onset seizures with or without secondary generalisation
in patients with epilepsy aged 4 years and older.
add-on therapy in the treatment of primary generalised tonic-clonic seizures in patients with
idiopathic generalised epilepsy aged 4 years and older.,Paediatric patents weighing less than 50 kg should not receive Lacosamide Sandoz film-coated
tablets. Paediatric patients weighing less than 50 kg should be accurately dosed on a mg/kg basis
with other lacosamide products.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on September, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Lacosamide Sandoz (lacosamide) tablets are indicated as:
monotherapy in the treatment of partial onset seizures with or without secondary generalisation
in patients with epilepsy aged 16 years and older.
add-on therapy in the treatment of partial onset seizures with or without secondary generalisation
in patients with epilepsy aged 4 years and older.
add-on therapy in the treatment of primary generalised tonic-clonic seizures in patients with
idiopathic generalised epilepsy aged 4 years and older.,Paediatric patents weighing less than 50 kg should not receive Lacosamide Sandoz film-coated
tablets. Paediatric patients weighing less than 50 kg should be accurately dosed on a mg/kg basis
with other lacosamide products.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Lacosamide Sandoz (lacosamide) tablets are indicated as:
monotherapy in the treatment of partial onset seizures with or without secondary generalisation
in patients with epilepsy aged 16 years and older.
add-on therapy in the treatment of partial onset seizures with or without secondary generalisation
in patients with epilepsy aged 4 years and older.
add-on therapy in the treatment of primary generalised tonic-clonic seizures in patients with
idiopathic generalised epilepsy aged 4 years and older.,Paediatric patents weighing less than 50 kg should not receive Lacosamide Sandoz film-coated
tablets. Paediatric patients weighing less than 50 kg should be accurately dosed on a mg/kg basis
with other lacosamide products.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on September, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.
